✦ LIBER ✦

Improved Nonrelapse Mortality and Infection Rate with Lower Dose of Antithymocyte Globulin in Patients Undergoing Reduced-Intensity Conditioning Allogeneic Transplantation for Hematologic Malignancies

✍ Scribed by Mehdi Hamadani; William Blum; Gary Phillips; Patrick Elder; Leslie Andritsos; Craig Hofmeister; Lynn O'Donnell; Rebecca Klisovic; Sam Penza; Ramiro Garzon; David Krugh; Thomas Lin; Thomas Bechtel; Don M. Benson; John C. Byrd; Guido Marcucci; Steven M. Devine

Book ID: 116281119
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 262 KB
Volume: 15
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2009.07.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fludarabine, Antithymocyte Globulin, and

Fludarabine, Antithymocyte Globulin, and Very Low-Dose Busulfan for Reduced-Intensity Conditioning before Allogeneic Stem Cell Transplantation in Patients with Lymphoid Malignancies

✍ Florent Malard; Xavier Cahu; Aline Clavert; Eolia Brissot; Patrice Chevallier; T 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Evaluation of Rabbit Antithymocyte Globu

Evaluation of Rabbit Antithymocyte Globulin (rATG) Dose-Intensity in Patients Undergoing Allogeneic Stem Cell Transplantation (ASCT) Following Reduced Intensity Conditioning (RIC) with Fludarabine, Busulfan and rATG (FBA)

✍ M. Hamadani; D.M. Benson Jr.; P. Porcu; P. Elder; L. Andritsos; C.C. Hofmeister; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Five Versus 2.5 mg/kg of Anti-Thymocyte-

Five Versus 2.5 mg/kg of Anti-Thymocyte-Globulin Dose in Reduced-Intensity-Conditioning Reduces Acute and Chronic Graft-Versus-Host Disease for Patients with Myeloid Malignancies Undergoing Allogeneic Stem Cell Transplantation

✍ R. Devillier; R. Crocchiolo; L. Castagna; S. Fürst; J. El Cheikh; C. Faucher; T. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Increasing the Dose of Busulfan Results

Increasing the Dose of Busulfan Results in Lower Relapse Rates and Higher Non-Relapse Mortality in Patients With MDS/AML Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation

✍ Y.-B. Chen; L. Sun; H. Kim; E.P. Alyea; P. Armand; E.C. Attar; K.K. Ballen; C. C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB

CD34+ Cell Dose and Full Donor Chimerism

CD34+ Cell Dose and Full Donor Chimerism at Day +100 Is Associated with Survival in Patients Who Received Reduced-Intensity Conditioning (RIC) With Fludarabine/Melphalan Prior To Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Hematologic Malignancies

✍ S.G. Holtan; W.J. Hogan; M.A. Elliott; D.A. Gastineau; T.G. Call; S.A. Ansell; D 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 62 KB